[Guest post] I hoped you’d like (culture) jamming too: ODEE, Samherji and the ECtHR [Guest post] I hoped you’d like (culture) jamming too: ODEE, Samherji and the ECtHR Reviewed by Eleonora Rosati on Monday, August 24, 2026 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Kliment Markov on Sunday, August 23, 2026 Rating: 5

Sunday Surprises

With the European summer gradually winding down, the IP world shows no signs of slowing. From a new minister responsible for intellectual pr...
- Sunday, August 23, 2026
Sunday Surprises Sunday Surprises Reviewed by Marcel Pemsel on Sunday, August 23, 2026 Rating: 5
Nuances of divisional patent practice in Australia and New Zealand Nuances of divisional patent practice in Australia and New Zealand Reviewed by Dr Claire Gregg on Friday, August 21, 2026 Rating: 5
Life Science Legal Strategy Summit relocates to Frankfurt with IPKat discount on Early Bird rate Life Science Legal Strategy Summit relocates to Frankfurt with IPKat discount on Early Bird rate Reviewed by Eleonora Rosati on Thursday, August 20, 2026 Rating: 5
[Guest post] Retromark Volume XVIII: the last six months in trade marks [Guest post] Retromark Volume XVIII: the last six months in trade marks Reviewed by Eleonora Rosati on Wednesday, August 19, 2026 Rating: 5
Is adverising with lawyer rankings lawful? Is adverising with lawyer rankings lawful? Reviewed by Marcel Pemsel on Wednesday, August 19, 2026 Rating: 5
Australian court orders withdrawal of patent applications prior to publication Australian court orders withdrawal of patent applications prior to publication Reviewed by Dr Claire Gregg on Wednesday, August 19, 2026 Rating: 5
SHEIN v Temu: Proving copyright ownership, and platform liability SHEIN v Temu: Proving copyright ownership, and platform liability Reviewed by Oliver Fairhurst on Monday, August 17, 2026 Rating: 5
Thinking beyond the sequence: CAR-T cell therapy litigation at the UPC (2seventy bio v Johnson & Johnson, UPC_CFI_029/2026) Thinking beyond the sequence: CAR-T cell therapy litigation at the UPC (2seventy bio v Johnson & Johnson, UPC_CFI_029/2026) Reviewed by Dr Rose Hughes on Monday, August 17, 2026 Rating: 5
Powered by Blogger.